Academic-Community Partnership and Deaths in Promyelocytic Leukemia
About this episode
The episode features an interview with Dr. Anand P. Jillella discussing the ECOG-ACRIN trial related to deaths in promyelocytic leukemia.
Interview with Anand P. Jillella, MD, author of Academic-Community Partnership and Deaths in Promyelocytic Leukemia: The Nonrandomized ECOG-ACRIN EA9131 Trial. Hosted by Vivek Subbiah, MD. Related Content: Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality
More episodes of JAMA Oncology Author Interviews
- Metastatic Recurrence Among Adolescents and Young Adults With Cancer
- Consistent Adherence to Physical Activity Guidelines and Digestive System Cancer Risk and Mortality
- Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer
- Proportional Sedation for Persistent Agitated Delirium in Palliative Care
- New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance
- Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury
Explore listener stats, chart rankings, contacts and more on the JAMA Oncology Author Interviews podcast page.